Exterior of Astellas Canada’s office, where teams develop innovative therapies with integrity and patient-first focus.

Canada news

Astellas is committed to providing timely and accurate information about our business, science and products. This section offers local resources for investors, journalists and media professionals. Global news and resources can be viewed here. If you are not an investor or journalist, click here.

Month Year

Month Year

Dec 3, 2024

VEOZAH® (fezolinetant film-coated tablets) Receives Health Canada Approval as First and Only Non-hormonal Treatment for Vasomotor Symptoms (VMS) Associated with Menopause

New treatment option helps fill unmet need for women experiencing hot flashes and night sweats associated with menopause MARKHAM, ON, December 3, 2024 – Today, Astellas Pharma Canada, Inc. is...

Read more about VEOZAH® (fezolinetant film-coated tablets) Receives Health Canada Approval as First and Only Non-hormonal Treatment for Vasomotor Symptoms (VMS) Associated with Menopause

Show per page

Discover more

Return to global media homepage

Canada

Follow Canada news

Subscribe to news alerts